EBITDA: Income before interest, taxes, depreciation and amortization.
BioAge Labs, Inc. (BIOA) had EBITDA of $-24.71M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.41M |
|
$-21.56M |
|
-- |
|
$2.41M |
|
$27.18M |
|
$-24.77M |
|
$3.21M |
|
$-21.56M |
|
$-21.56M |
|
$-21.56M |
|
$-21.56M |
|
$-21.56M |
|
$-21.56M |
|
$-24.77M |
|
|
EBITDA |
$-24.71M |
35.85M |
|
35.85M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$301.70M |
|
$0.97M |
|
$20.45M |
|
$322.15M |
|
$22.84M |
|
-- |
|
$4.53M |
|
$27.37M |
|
$294.78M |
|
$294.78M |
|
$294.78M |
|
35.85M |
|
| Cash Flow Statement Financials | |
$-37.33M |
|
$-93.63M |
|
$-3.00M |
|
$354.35M |
|
$220.33M |
|
$-134.02M |
|
$6.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.21 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
100.00% |
|
-1026.99% |
|
-1026.99% |
|
-- |
|
-893.99% |
|
-893.99% |
|
$-37.92M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
4.00 |
|
22.50 |
|
-7.31% |
|
-7.31% |
|
-6.69% |
|
-7.31% |
|
$8.22 |
|
$-1.06 |
|
$-1.04 |
|